GynecologyGynecology2079-56962079-5831Consilium Medicum27993Research Article«Mirena» – kak effektivnyyi priemlemyy metod kontratseptsii.Analiz pobochnykh reaktsiyRevazovaF S-PrilepskayaV N-15022009111384109042020Copyright © 2009, Consilium Medicum2009[Coleman M. Levonorgestrel - releasing IUD – more than only a contraceptive method. Aust NZ Obstet Gynaecol 1997; 37 (2).][Critchley H.O, Wang H, Kelly R.W et al. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of the women using a levonorgestre - releasing intrauterine system. Human Reprod 1998; 13 (5): 1210–7.][Critchley H.O.D, Wang H, Jones R et al. Morphological and functional features of endometrial decidualisation following long - term intrauterine levonorgestrel delivery. Hum Reprod 1998; 13 (5): 1218–24.][Gerber B, Reimer T, Krause A et al. Levonorgestrel - releasing intrauterine devices. Lancet 2001; 10: 357.][Goran Rybo, Kerstin Andersson, Viveca Odlind. Hormonal intrauterine devices. Ann Med 1993; 25: 143–7.][Kunz J. Levonorgestrel releasing intrauterine spiral - contraception – therapeutic indications. Schweiz Rundsch Med Prax 2001; 90: 442–52.][Lu S.M. Effect of levonorgestrel intrauterine device on human endometrial estrogen and progesterone receptors. Chung - Hua - Fu - Chan - Ko - Tsa - Chin 1991; 26 (5):293–4.][Luukkainen T, Pakarinen P, Toivonen J. Progestin - releasing intrauterine systems. Semin Reprod Med 2001; 19 (4): 355–64.][Mirena. Product monograph. Shering A.G. 2002.][Oliveira da Silva M, Costa M. Reasons, myths and fantasies: preliminary data and reflections about the Portuguese experience with LNG - IUS - induced hypomenorrhea. The Europ J Contracep Reprod Health Care 1999; 4: 21.][Ronnerdag M. Health effects of long - term use of the LNG - IUS. Abstracts book. Mirena – effective contraception with health benefits. 2001; 10–1.][Ronnerdag M, Odlind V. Health effect of long - term use of the intrauterine levonorgestrel - releasing system. A follow - up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999; 78 (8): 716–21.][Rutanen E.M. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum 1998; 3 (3):11–4.][Rutanen E.M. Insulin - like growth factors and insulin - like growth factor binding proteins in the endometrium. Effect of the intrauterinelevonorgestrel - delivery. Hum Reprod 2001; 15 (3): 173–81.][Sturridge F, Guillebaud J. A risk - benefit assessment of the levonorgestrel - releasing intrauterine system. Drug Safety 1996; 15 (6): 430–40.][Wildemeersch D, Schacht E, Thiery M et al. Intrauterine contraception in the year 2001: can intrauterine devices use be revived with new improved contracetive technology? The Eur J Contacep Reprod Health Care 2000; 5: 295–304.][Zhou J, Dsupin B.A, Gindice L.C et al. Insulin - like growth factor (IGF) IGF binding protein and IGF receptor gene expression in human endometrium. J Con Endocrinol Metab 1994; 79: 1723–34.]